Two brand-new COVID-19 pills that were supposed to be an important weapon against the pandemic in the U.S. are in short supply and have played little role in the fight against the omicron wave of infections. The problem, in part, is that production is still being ramped up and the medicines can take anywhere from five to eight months to manufacture. While the supply is expected to improve dramatically in the coming months, doctors are clamoring for the pills now…